Related Experiment Videos
Nodular adrenal hyperplasia with elevated adrenocorticotropic hormone levels
Archives of Internal Medicine
|January 1, 1983
Summary
Micronodular adrenal hyperplasia is an uncommon adrenal disorder. This case suggests hypothalamic-pituitary hyperfunction may precede the development of micronodular adrenal disease.
Area of Science:
- Endocrinology
- Adrenal Disorders
- Neuroendocrinology
Background:
- Micronodular adrenal hyperplasia (MAH) is a rare adrenal condition.
- MAH is characterized by resistance to high-dose dexamethasone suppression of urinary corticosteroids.
- Its origin, whether adrenal or pituitary-hypothalamic, remains debated due to variable ACTH levels.
Observation:
- A patient presented with Cushing's syndrome and non-suppressible urinary corticosteroids.
- Adrenocorticotropic hormone (ACTH) levels were elevated but suppressed with high-dose dexamethasone.
- Surgical examination revealed enlarged adrenal glands with micronodules.
Findings:
- The patient's presentation challenges the typical understanding of MAH.
- Elevated and suppressible ACTH levels suggest a central (pituitary-hypothalamic) origin.
- This contrasts with the adrenal autonomy often presumed in MAH.
Implications:
- This case supports the hypothesis that hypothalamic-pituitary overactivity can initiate MAH.
- Understanding the central-adrenal interplay is crucial for diagnosing and managing MAH.
- Further research into the neuroendocrine regulation of the adrenal gland is warranted.